Highlights and Quick Summary
- Total non-current liabilities for the quarter ending December 31, 2022 was $11.1 Million (a -6.55% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities decreased by -95.31%
- Annual Total non-current liabilities for 2022 was $11.1 Million (a -94.92% decrease from previous year)
- Annual Total non-current liabilities for 2021 was $218 Million (a 6.13% increase from previous year)
- Annual Total non-current liabilities for 2020 was $205 Million (a -21.39% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of Precigen, Inc.
Most recent Total non-current liabilitiesof PGEN including historical data for past 10 years.Interactive Chart of Total non-current liabilities of Precigen, Inc.
Precigen, Inc. Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $11.07 | $11.85 | $235.67 | $236.13 | $11.07 |
| 2021 | $217.86 | $216.66 | $214.51 | $206.95 | $217.86 |
| 2020 | $205.29 | $246.97 | $248.07 | $246.81 | $205.29 |
| 2019 | $261.14 | $294.53 | $324.33 | $315.62 | $261.14 |
| 2018 | $275.89 | $332.64 | $174.77 | $184.96 | $275.89 |
| 2017 | $220.13 | $257.29 | $266.75 | $275.12 | $220.13 |
| 2016 | $285.22 | $296.65 | $307.43 | $209.66 | $285.22 |
| 2015 | $201.26 | $183.17 | $183.21 | $117.94 | $201.26 |
| 2014 | $119.5 | $119.4 | $91.48 | $93.7 | $119.5 |
| 2013 | – | $68.3 | $63.27 | $59.61 | $68.3 |
| 2012 | – | – | – | – | $49.82 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology